Search results for "heart diseases"

showing 10 items of 115 documents

Alteraciones en los pies en ancianos frágiles comunitarios con patología cardíaca. Factores de riesgo

2016

Medicine(all)Cartas al directorlcsh:R5-920Heart Diseasesbusiness.industryFrail ElderlyGeneral Medicine030204 cardiovascular system & hematologyFoot Diseases03 medical and health sciences0302 clinical medicineRisk FactorsHumansMedicineIndependent Living030212 general & internal medicineFamily Practicebusinesslcsh:Medicine (General)Geriatric AssessmentAgedAtención Primaria
researchProduct

Lipomatous Metaplasia. Two Chronic Infarcts in the Same Patient Detected by Cardiac Magnetic Resonance

2009

MetaplasiaPathologymedicine.medical_specialtyHeart DiseasesLipomatous Metaplasiabusiness.industryMyocardiumMyocardial InfarctionGeneral MedicineMagnetic Resonance ImagingChronic DiseasemedicineHumansLipomatosisCardiac magnetic resonancebusinessRevista Española de Cardiología (English Edition)
researchProduct

Modelización computacional cardiaca

2020

[EN] Cardiovascular diseases currently have a major social and economic impact, constituting one of the leading causes of mortality and morbidity. Personalized computational models of the heart are demonstrating their usefulness both to help understand the mechanisms underlying cardiac disease, and to optimize their treatment and predict the patient's response. Within this framework, the Spanish Research Network for Cardiac Computational Modelling (VHeart-SN) has been launched. The general objective of the VHeart-SN network is the development of an integrated, modular and multiscale multiphysical computational model of the heart. This general objective is addressed through the following spe…

Modelos cardiovascularesHeart DiseasesDisease030204 cardiovascular system & hematologyPatient-specific modelsTECNOLOGIA ELECTRONICA03 medical and health sciencesMultiscale modelling0302 clinical medicineHumansMedicine03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edadesEconomic impact analysisModelos cardiacosModelos específicos de pacienteComputational modelCardiovascular modelsbusiness.industryModelos multiescalaHeartGeneral MedicineModular design3. Good healthCardiac modelsRisk analysis (engineering)business
researchProduct

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

2015

BACKGROUND: Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular disease. METHODS: In this randomized, double-blind study, we assigned 14,671 patients to add either sitagliptin or placebo to their existing therapy. Open-label use of antihyperglycemic therapy was encouraged as required, aimed at reaching individually appropriate glycemic targets in all patients. To determine whether sitagliptin was noninferior to placebo, we used a relative risk of 1.3 as the marginal upper boundary. The primary cardiovascular outcome was a composite of cardiovascular deat…

Oralmedicine.medical_specialtyHeart diseasesGlycosylatedAdministration Oralheart failureType 2 diabetesDipeptidyl peptidase-4 inhibitorKaplan-Meier EstimatePlaceboSitagliptin PhosphateSitagliptin Cardiovascular Outcomeschemistry.chemical_compoundDrug TherapyDouble-Blind MethodInternal medicineDiabetes MellitusmedicineHumansHypoglycemic AgentsGlycated HemoglobinHemoglobin A GlycosylatedAdministration Oral; Cardiovascular Diseases; Diabetes Mellitus Type 2; Double-Blind Method; Drug Therapy Combination; Follow-Up Studies; Heart Diseases; Heart Failure; Hemoglobin A Glycosylated; Hospitalization; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Pyrazines; Sitagliptin Phosphate; Triazoles; Medicine (all)business.industryMedicine (all)SemaglutideSitagliptin PhosphateHemoglobin AGeneral MedicineTriazolesta3121medicine.diseaseSurgeryHospitalizationCardiovascular diseaseschemistryDiabetes Mellitus Type 2SitagliptinPyrazinesAdministrationCombinationDrug Therapy CombinationGlycated hemoglobinbusinessType 2Alogliptinmedicine.drugFollow-Up StudiesNew England Journal of Medicine
researchProduct

Cardiac Stem Cell Research: An Elephant in the Room?

2009

Heart disease is the leading cause of death in the industrialized world, and stem cell therapy seems to be a promising treatment for injured cardiac tissue. To reach this goal, the scientific community needs to find a good source of stem cells that can be used to obtain new myocardium in a very period range of time. Since there are many ethical and technical problems with using embryonic stem cells as a source of cells with cardiogenic potential, many laboratories have attempted to isolate potential cardiac stem cells from several tissues. The best candidates seem to be cardiac "progenitor" and/or "stem" cells, which can be isolated from subendocardial biopsies from the same patient or from…

Pathologymedicine.medical_specialtyHistologyHeart Diseasesmedicine.medical_treatmentCD34heart failureStem-cell therapyBiologyEmbryonic stem cellCell therapyEmbryo ResearchAmniotic epithelial cellsmedicineHumanscardiac immature cellcell therapyAnatomyStem cellEmbryonic Stem CellsEcology Evolution Behavior and SystematicsStem Cell TransplantationBiotechnologyAdult stem cellStem cell transplantation for articular cartilage repairThe Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology
researchProduct

Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants

2014

Acute bronchiolitis is the leading cause of lower respiratory t ract infection and hospitalization in children less than 1y ear of age worldwide. It is usually a mild disease, but some children may develop severe symptoms, requiring hospital admission and ventilatory support in the ICU. Infants with pre-existing risk factors (prematurity, bronchopulmonary dysplasia, congenital heart diseases and immunodeficiency) may be predisposed to a severe form of the disease. Clinical diagnosis of bronchiolitis is manly based on medical history and physical examination (rhinorrhea, cough, crackles, wheezing and signs of respiratory distress). Etiological diagnosis, with antigen or genome detection to i…

PediatricsBronchiolitis; Bronchopulmonary dysplasia; Congenital heart diseases; Immunodeficiency; Oxygen therapy; Prematurity; Prevention; Prophylaxis; Respiratory syncytial virus;ReviewRespiratory syncytial virusSeverity of Illness IndexCongenital heart diseasesSettore MED/38 - Pediatria Generale E SpecialisticaAdrenergic beta-2 Receptor AntagonistsVitamin DChildrenRespiratory distressVitaminsEnvironmental exposurePatient DischargeAnti-Bacterial AgentsBronchodilator AgentsHospitalizationSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICABronchiolitisbronchiolitisPrematuritymedicine.drugPalivizumabRespiratory Therapymedicine.medical_specialtyEpinephrineDecision MakingAntibodies Monoclonal HumanizedAntiviral AgentsIntensive Care Units NeonatalBronchiolitis Respiratory syncytial virus Prematurity Bronchopulmonary dysplasia Congenital heart diseases Immunodeficiency Oxygen therapy Prevention ProphylaxismedicineHumansImmunodeficiencyAcute bronchiolitisMedical historyConsensus DocumentIntensive care medicineGlucocorticoidsPalivizumabAsthmaSaline Solution HypertonicPrimary Health CareProphylaxisbusiness.industryNebulizers and VaporizersPreventionInfant NewbornOxygen Inhalation TherapyHumidityEnvironmental ExposureAcute bronchiolitis Consensus Documentmedicine.diseaseBronchopulmonary dysplasiaOxygen therapyHypertonic salineBronchopulmonary dysplasiaBronchiolitisbusinessItalian Journal of Pediatrics
researchProduct

Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFup.

2016

Background and AimChildhood cancer survivors are at high risk of long-term adverse effects of cancer and its treatment, including cardiac events. The pan-European PanCareSurFup study determined the incidence and risk factors for cardiac events among childhood cancer survivors. The aim of this article is to describe the methodology of the cardiac cohort and nested case-control study within PanCareSurFup.MethodsEight data providers in Europe participating in PanCareSurFup identified and validated symptomatic cardiac events in their cohorts of childhood cancer survivors. Data on symptomatic heart failure, ischemia, pericarditis, valvular disease and arrhythmia were collected and graded accordi…

PediatricsCritical Care and Emergency MedicineCancer Treatmentlcsh:MedicineADULT SURVIVORSCHILDREN030204 cardiovascular system & hematologyDOXORUBICIN THERAPYPediatricsCohort Studies0302 clinical medicineRisk FactorsNeoplasmsMedicine and Health SciencesSurvivorsYoung adultChildlcsh:Scienceeducation.field_of_studyMultidisciplinaryGUIDELINE HARMONIZATION GROUPCancer Risk Factors3. Good healthEuropeOncologyHelminth Infections030220 oncology & carcinogenesisChild PreschoolCohortHEALTH OUTCOMESRecord linkageCohort studyResearch ArticleNeglected Tropical DiseasesAdultCARDIOTOXICITYmedicine.medical_specialtyAdolescentHeart DiseasesLONG-TERMPopulationCardiology610 Medicine & health03 medical and health sciencesYoung Adult360 Social problems & social servicesDiagnostic MedicineEchinococcosismedicineCancer Detection and DiagnosisParasitic DiseasesHumanseducationAdverse effectCONGESTIVE-HEART-FAILUREbusiness.industryMORTALITYlcsh:RCase-control studyCancerInfantmedicine.diseaseTropical DiseasesPediatric OncologyCase-Control StudiesRISK-FACTORSlcsh:QbusinessPLoS ONE
researchProduct

Isolated myocardiocytes and DNA synthesis: a possible experimental model to predict the in vivo cardiotoxicity

1989

PharmacologyCardiotoxicityHeart DiseasesDNA synthesisBiological modelingbusiness.industryExperimental modelMyocardiumDNAPharmacologyModels BiologicalRatsMiceDoxorubicinIn vivoToxicityAnimalsMedicineMitoxantronebusinessPharmacological Research
researchProduct

Effects of verapamil and N-acetylcysteine on doxorubicin or isoproterenol cardiotoxicity in mice

1989

PharmacologyCardiotoxicitymedicine.medical_specialtyHeart Diseasesbusiness.industryIsoproterenolPharmacologyAcetylcysteineAcetylcysteineMiceEndocrinologyVerapamilDoxorubicinInternal medicineHeart Function TestsmedicineAnimalsVerapamilDoxorubicinbusinessmedicine.drugPharmacological Research
researchProduct

The appropriate and justified use of medical radiation in cardiovascular imaging: a position document of the ESC Associations of Cardiovascular Imagi…

2014

The benefits of cardiac imaging are immense, and modern medicine requires the extensive and versatile use of a variety of cardiac imaging techniques. Cardiologists are responsible for a large part of the radiation exposures every person gets per year from all medical sources. Therefore, they have a particular responsibility to avoid unjustified and non-optimized use of radiation, but sometimes are imperfectly aware of the radiological dose of the examination they prescribe or practice. This position paper aims to summarize the current knowledge on radiation effective doses (and risks) related to cardiac imaging procedures. We have reviewed the literature on radiation doses, which can range …

Prenatal Diagnosimedicine.medical_treatmentScintigraphyImagingPregnancyRisk FactorsPrenatal DiagnosisCancer; Cardiovascular disease; Imaging; Radiation; Radiological protection; Risk; Cardiac Imaging Techniques; Cardiology; Child; Female; Heart Diseases; Humans; Informed Consent; Occupational Exposure; Pregnancy; Pregnancy Complications; Prenatal Diagnosis; Radiation Injuries; Radiation Protection; Risk Factors; Tomography X-Ray Computed; Unnecessary Procedures; Radiation Dosage; Cardiology and Cardiovascular MedicineRadiation InjurieChildTomographyRadiological protectionCardiac imagingCancerRadiationInformed Consentmedicine.diagnostic_testCardiovascular diseasePregnancy ComplicationX-Ray ComputedHeart DiseaseFemaleRadiologyCardiology and Cardiovascular MedicineHumanUnnecessary ProcedureRiskmedicine.medical_specialtyModern medicineHeart DiseasesCardiologyUnnecessary ProceduresRadiation DosageMyocardial perfusion imagingRadiation ProtectionOccupational ExposuremedicineMedical imagingHumansMedical physicsRadiation Injuriesta3126Cardiac Imaging Techniquebusiness.industryRisk FactorPercutaneous coronary interventionMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREta3121Pregnancy ComplicationsCardiac Imaging TechniquesCardiac Imaging TechniquesRadiation protectionTomography X-Ray Computedbusiness
researchProduct